INS and type 1 diabetes mellitus: Over 90% of people with newly diagnosed type 1 diabetes have measurable serum antibodies against specific β-cell proteins, including insulin (IAA), glutamate decarboxylase (GADA), islet antigen 2 (IA2A), zinc transporter 8 (ZnT8A).